106 related articles for article (PubMed ID: 2547048)
1. Vimentin--a new prognostic parameter in breast carcinoma?
Raymond WA; Leong AS
J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium.
Raymond WA; Leong AS
J Pathol; 1989 Apr; 157(4):299-306. PubMed ID: 2469782
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
[TBL] [Abstract][Full Text] [Related]
4. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.
Domagala W; Lasota J; Bartkowiak J; Weber K; Osborn M
Am J Pathol; 1990 Jan; 136(1):219-27. PubMed ID: 2153347
[TBL] [Abstract][Full Text] [Related]
5. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor cell proliferation rate as determined by the MIB-1 antibody in breast carcinoma: its relationship with vimentin and p53 protein.
Domagala W; Markiewski M; Harezga B; Dukowicz A; Osborn M
Clin Cancer Res; 1996 Jan; 2(1):147-54. PubMed ID: 9816101
[TBL] [Abstract][Full Text] [Related]
7. Oestrogen receptor staining of paraffin-embedded breast carcinomas following short fixation in formalin: a comparison with cytosolic and frozen section receptor analyses.
Raymond WA; Leong AS
J Pathol; 1990 Apr; 160(4):295-303. PubMed ID: 2162939
[TBL] [Abstract][Full Text] [Related]
8. Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breast.
Giani C; Campani D; De Negri F; Capotorti E; Savarese MR; Benigni G; Incensati RM; Breccia M; Miccoli P; Evangelista G
Appl Pathol; 1989; 7(4):225-32. PubMed ID: 2553078
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 protein has no independent prognostic value in breast cancer.
Pietiläinen T; Lipponen P; Aaltomaa S; Eskelinen M; Kosma VM; Syrjänen K
J Pathol; 1995 Nov; 177(3):225-32. PubMed ID: 8551383
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast.
Ellis IO; Bell J; Ronan JE; Elston CW; Blamey RW
J Pathol; 1988 Feb; 154(2):157-65. PubMed ID: 2450980
[TBL] [Abstract][Full Text] [Related]
12. [Demonstration and possible prognostic value of the nucleolar organizer region (NOR), the microtubule-associated proteins 1A/1B (MAP) and the intermediate filaments vimentin and cytokeratin 19 in invasive ductal breast carcinoma].
Friedrich K; Sturm U; Dimmer U; Flössel C
Zentralbl Pathol; 1994 Mar; 140(1):61-71. PubMed ID: 7515675
[TBL] [Abstract][Full Text] [Related]
13. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
Sharif MA; Mamoon N; Mushtaq S; Khadim MT
J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
[TBL] [Abstract][Full Text] [Related]
14. Vimentin expression does not assist in predicting survival in ductal carcinoma of the breast.
Heatley MK; Ewings P; Odling Smee W; Maxwell P; Toner PG
Pathology; 2002 Jun; 34(3):230-2. PubMed ID: 12109782
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
[TBL] [Abstract][Full Text] [Related]
16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
17. TGF alpha and TGF beta expression in mammary carcinoma.
Dublin EA; Barnes DM; Wang DY; King RJ; Levison DA
J Pathol; 1993 May; 170(1):15-22. PubMed ID: 8392105
[TBL] [Abstract][Full Text] [Related]
18. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
Looi LM; Cheah PL
Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
[TBL] [Abstract][Full Text] [Related]
19. Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.
Hemalatha A; Suresh TN; Kumar ML
Indian J Cancer; 2013; 50(3):189-94. PubMed ID: 24061457
[TBL] [Abstract][Full Text] [Related]
20. The relationship between growth fractions and oestrogen receptors in human breast carcinoma, as determined by immunohistochemical staining.
Raymond WA; Leong AS
J Pathol; 1989 Jul; 158(3):203-11. PubMed ID: 2769481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
